Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Correction: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments (Trials, (2022), 23, 1, (62), 10.1186/s13063-021-05965-4)

Cake C. et al, (2023), Trials, 24

Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure

Wade J. et al, (2023), Trials, 24

A targeted approach to vaccine hesitancy

Leston M. et al, (2023), Oxford Open Immunology

COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study

Whitaker HJ. et al, (2023), Journal of Infection, 87, 315 - 327

The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease.

Groehl F. et al, (2023), Clin Nephrol, 100, 145 - 156

Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI

Koshiaris C. et al, (2023), The British journal of general practice : the journal of the Royal College of General Practitioners, 73, e605 - e614

Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19)

Nicholson BD. et al, (2023), PLoS ONE, 18

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study

Nicholson BD. et al, (2023), The Lancet Oncology, 24, 733 - 743

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study

Tsang RSM. et al, (2023), British Journal of General Practice, 73, E435 - E442

Body mass index and survival in people with heart failure

JONES N. et al, (2023), Heart

The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study

Sheppard JP. et al, (2023), PLOS Medicine, 20, e1004223 - e1004223

Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis.

Hartmann-Boyce J. et al, (2023), Circ Cardiovasc Qual Outcomes

Evaluating the transmission risk of SARS-CoV-2 from sewage pollution

Ransome E. et al, (2023), Science of the Total Environment, 858

Weight regain after behavioural weight management programmes and its impact on quality of life and cost effectiveness: Evidence synthesis and health economic analyses

Hartmann-Boyce J. et al, (2023), Diabetes, Obesity and Metabolism, 25, 526 - 535

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.

Bedston S. et al, (2023), Vaccine

BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data.

Virdee PS. et al, (2023), Diagn Progn Res, 7

Face masks while exercising trial (MERIT): a cross-over randomised controlled study

Jones N. et al, (2023), BMJ open, 13

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

Tsang RS. et al, (2023), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 28

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)

Kijak GH. et al, (2023), Infectious Diseases and Therapy

Load More

1
2
3
4
5
6
7
...
»